Form 8-K - Current report:
SEC Accession No. 0000950123-08-013619
Filing Date
2008-10-28
Accepted
2008-10-28 16:15:35
Documents
2
Period of Report
2008-10-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y00387e8vk.htm 8-K 12600
2 EX-99.1: PRESS RELEASE y00387exv99w1.htm EX-99.1 3205
  Complete submission text file 0000950123-08-013619.txt   17558
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 081144983
SIC: 2836 Biological Products, (No Diagnostic Substances)